FDA Approves Merck's Keytruda for Lung Cancer

Merck’s Keytruda has received Food and Drug Administration approval for the treatment of non-small cell lung cancer, which accounts for about 85% to 90% of all lung-cancer cases.

from WSJ.com: US Business http://ift.tt/1GoSyBz
via IFTTT